184 related articles for article (PubMed ID: 10559007)
1. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix.
Marathe S; Kuriakose G; Williams KJ; Tabas I
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2648-58. PubMed ID: 10559007
[TBL] [Abstract][Full Text] [Related]
2. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.
Schissel SL; Jiang X; Tweedie-Hardman J; Jeong T; Camejo EH; Najib J; Rapp JH; Williams KJ; Tabas I
J Biol Chem; 1998 Jan; 273(5):2738-46. PubMed ID: 9446580
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation.
Tabas I; Li Y; Brocia RW; Xu SW; Swenson TL; Williams KJ
J Biol Chem; 1993 Sep; 268(27):20419-32. PubMed ID: 8376399
[TBL] [Abstract][Full Text] [Related]
4. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.
Schissel SL; Tweedie-Hardman J; Rapp JH; Graham G; Williams KJ; Tabas I
J Clin Invest; 1996 Sep; 98(6):1455-64. PubMed ID: 8823312
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation.
Marathe S; Choi Y; Leventhal AR; Tabas I
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2607-13. PubMed ID: 11116060
[TBL] [Abstract][Full Text] [Related]
6. Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling.
Marathe S; Schissel SL; Yellin MJ; Beatini N; Mintzer R; Williams KJ; Tabas I
J Biol Chem; 1998 Feb; 273(7):4081-8. PubMed ID: 9461601
[TBL] [Abstract][Full Text] [Related]
7. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis.
Wong ML; Xie B; Beatini N; Phu P; Marathe S; Johns A; Gold PW; Hirsch E; Williams KJ; Licinio J; Tabas I
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8681-6. PubMed ID: 10890909
[TBL] [Abstract][Full Text] [Related]
8. Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans.
Oörni K; Posio P; Ala-Korpela M; Jauhiainen M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1678-83. PubMed ID: 15879301
[TBL] [Abstract][Full Text] [Related]
9. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression.
Devlin CM; Leventhal AR; Kuriakose G; Schuchman EH; Williams KJ; Tabas I
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1723-30. PubMed ID: 18669882
[TBL] [Abstract][Full Text] [Related]
10. Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.
Pillarisetti S; Paka L; Obunike JC; Berglund L; Goldberg IJ
J Clin Invest; 1997 Aug; 100(4):867-74. PubMed ID: 9259586
[TBL] [Abstract][Full Text] [Related]
11. Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet.
Deevska GM; Sunkara M; Morris AJ; Nikolova-Karakashian MN
Biosci Rep; 2012 Oct; 32(5):479-90. PubMed ID: 22712892
[TBL] [Abstract][Full Text] [Related]
12. Secretory sphingomyelinase.
Tabas I
Chem Phys Lipids; 1999 Nov; 102(1-2):123-30. PubMed ID: 11001566
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic roles of lipoprotein lipase and sphingomyelinase in low density lipoprotein aggregation.
Walters MJ; Wrenn SP
J Colloid Interface Sci; 2011 Nov; 363(1):268-74. PubMed ID: 21839462
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix.
Saxena U; Ferguson E; Bisgaier CL
J Biol Chem; 1993 Jul; 268(20):14812-9. PubMed ID: 8325860
[TBL] [Abstract][Full Text] [Related]
15. Formation of intimal cushions in the ductus arteriosus as a model for vascular intimal thickening. An immunohistochemical study of changes in extracellular matrix components.
Slomp J; van Munsteren JC; Poelmann RE; de Reeder EG; Bogers AJ; Gittenberger-de Groot AC
Atherosclerosis; 1992 Mar; 93(1-2):25-39. PubMed ID: 1596302
[TBL] [Abstract][Full Text] [Related]
16. Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix.
Lundstam U; Hurt-Camejo E; Olsson G; Sartipy P; Camejo G; Wiklund O
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1162-7. PubMed ID: 10323765
[TBL] [Abstract][Full Text] [Related]
17. Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles. Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans.
Oörni K; Hakala JK; Annila A; Ala-Korpela M; Kovanen PT
J Biol Chem; 1998 Oct; 273(44):29127-34. PubMed ID: 9786921
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient mice.
Maor I; Hayek T; Hirsh M; Iancu TC; Aviram M
Atherosclerosis; 2000 May; 150(1):91-101. PubMed ID: 10781639
[TBL] [Abstract][Full Text] [Related]
19. Native and minimally oxidized low density lipoprotein depress smooth muscle matrix metalloproteinase levels.
Wilson D; Massaeli H; Pierce GN; Zahradka P
Mol Cell Biochem; 2003 Jul; 249(1-2):141-9. PubMed ID: 12956409
[TBL] [Abstract][Full Text] [Related]
20. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions.
Ylä-Herttuala S; Lipton BA; Rosenfeld ME; Goldberg IJ; Steinberg D; Witztum JL
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10143-7. PubMed ID: 1719546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
